---
figid: PMC2360215__6603520f1
figtitle: Activation of the RAS–RAF–MEK pathway in thyroid cancer
organisms:
- Homo sapiens
- Mus musculus
- clinical samples
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC2360215
filename: 6603520f1.jpg
figlink: /pmc/articles/PMC2360215/figure/fig1/
number: F1
caption: Activation of the RAS–RAF–MEK pathway in thyroid cancer. Constitutive activation
  via gene mutations or rearrangements in RET, RAS and BRAF (highlighted in red) are
  the principal initiators of thyroid cancer development through enhanced nuclear
  translocation of ERK and subsequent transcriptional regulation of target genes.
  Activation of this tumour initiation pathway occurs in ∼70% of thyroid cancers.
  Activation of other pathways that cooperatively activate ERK, as well regulate other
  cell signaling pathways may also be involved with ERK in thyroid cancer progression.
  *Proteins known to be constitutively activated in thyroid cancer.
papertitle: Targeting BRAF in thyroid cancer.
reftext: A V Espinosa, et al. Br J Cancer. 2007 Jan 15;96(1):16-20.
year: '2007'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9026619
figid_alias: PMC2360215__F1
figtype: Figure
redirect_from: /figures/PMC2360215__F1
ndex: 331c660f-deb4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2360215__6603520f1.html
  '@type': Dataset
  description: Activation of the RAS–RAF–MEK pathway in thyroid cancer. Constitutive
    activation via gene mutations or rearrangements in RET, RAS and BRAF (highlighted
    in red) are the principal initiators of thyroid cancer development through enhanced
    nuclear translocation of ERK and subsequent transcriptional regulation of target
    genes. Activation of this tumour initiation pathway occurs in ∼70% of thyroid
    cancers. Activation of other pathways that cooperatively activate ERK, as well
    regulate other cell signaling pathways may also be involved with ERK in thyroid
    cancer progression. *Proteins known to be constitutively activated in thyroid
    cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ret
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Braf
  - Braf-rs1
  - Mdk
  - Ephb2
  - Mapk1
  - Mapk3
  - RET
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - KDR
  - FLT1
  - FLT4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - reticulated
  - reti
  - rets
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Ras64B
  - Ras85D
  - Pvr
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - ret
  - kita
  - ngfra
  - rab1ab
  - braf
  - si:dkey-222f8.3
  - mapk3
  - Cancer
  - Lung cancer
---
